IMG Wealth Management Inc. Invests $136,000 in HCA Healthcare, Inc. (NYSE:HCA)

IMG Wealth Management Inc. purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 454 shares of the company’s stock, valued at approximately $136,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Legacy Investment Solutions LLC acquired a new stake in shares of HCA Healthcare during the third quarter worth $39,000. Whipplewood Advisors LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $31,000. Tidemark LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $36,000. Activest Wealth Management raised its holdings in shares of HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. increased its stake in HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on HCA shares. Royal Bank of Canada cut their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research report on Monday, January 27th. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Barclays decreased their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday, January 27th. Morgan Stanley decreased their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Finally, Truist Financial reduced their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $385.67.

Check Out Our Latest Research Report on HCA Healthcare

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $319.82 on Monday. The stock has a market capitalization of $78.74 billion, a PE ratio of 14.56, a P/E/G ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The business has a fifty day moving average price of $319.00 and a two-hundred day moving average price of $344.95. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the firm posted $5.90 earnings per share. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.90%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is 13.11%.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.